AbbVie, Deere And A Major Chipmaker Set To Win In AI: CNBC's 'Final Trades'
Portfolio Pulse from Lisa Levin
CNBC's 'Halftime Report Final Trades' highlighted AbbVie, Deere & Company, and Broadcom as potential winners. AbbVie reported VRAYLAR reimbursement under the NIHB Program, Deere may return to over $400 level, and Broadcom is expected to benefit from AI advancements. EU Antitrust Regulators are set to approve Broadcom's acquisition of VMware.
June 13, 2023 | 12:48 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AbbVie reported VRAYLAR reimbursement under the NIHB Program, which may positively impact its stock price.
AbbVie's VRAYLAR reimbursement under the NIHB Program is a positive development for the company, which may lead to increased revenues and a potential positive impact on its stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Broadcom is expected to benefit from AI advancements and EU Antitrust Regulators are set to approve its acquisition of VMware.
Broadcom's potential to benefit from AI advancements and the approval of its acquisition of VMware by EU Antitrust Regulators may lead to increased revenues and a positive impact on its stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Deere & Company may return to over $400 level, according to Stephen Weiss of Short Hills Capital Partners.
Stephen Weiss's prediction of Deere & Company returning to over $400 level is based on his expertise and analysis, which may lead to a positive impact on the stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100